Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI) Bryan, Garnier & Co acts as Sole Financial Advisor to TVH Consulting and its shareholders on its secondary LBO with 21 Invest Bryan, Garnier & Co acts as Sole Financial Advisor to Qred on its Private Placement pursued by Nordic Capital Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of Goverlan, Inc and its financing by Blackrock Bryan, Garnier & Co acts as Sole Financial Advisor to Arturia on its capital and debt reorganization led by its management team and EMZ Partners Bryan, Garnier & Co acts as Sole Financial Advisor to the French cloud operator Oceanet Technology and its shareholders on its sale to Celeste, the InfraVia-backed French telecom operator Deal Aleph Bryan, Garnier & Co acts as Joint Bookrunner on Mister Spex’s EUR 326 million Initial Public Offering Bryan, Garnier & Co acts as Sole Financial Strategic Advisor, Sole Global Coordinator and Joint Bookrunner to HDF Energy on its EUR 132.2 million Initial Public Offering including Strategic Investments from Rubis and Teréga Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Heidelberg Pharma’s EUR 20 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Abivax’s EUR 85 million Follow-on Offering & Convertible Bonds Issuance
